摘要
目的探讨难治性下肢动脉硬化闭塞症(arteriosclerosis obliterans,ASO)的腔内治疗效果。方法回顾2007年1月至2011年11月血管外科收治的43例TASCⅡ分级在B～D级、踝肱指数(ankle brachial index,ABI)为0～0.4的ASO患者腔内治疗的临床及随访资料。结果技术成功率91.8%(45/49)。与治疗前比较,踝肱指数平均升高0.24±0.13,差异有统计学意义(P<0.05)。术后症状完全缓解36例,好转4例,无明显改善3例;随访截肢率5%(2/40),病死率为2.5%(1/40)。结论腔内治疗具有微创、可重复操作性,腔内成形(球囊扩张)+支架植入术作为难治性ASO的首选外科治疗手段,近期疗效满意,远期疗效尚待进一步观察。
Objective To discuss the effect of endovascular treatment on refractory arteriosclerosis obliterans. Methods Forty - three cases of ASO graded B ~ D in TASC II were admitted in our hospital from January 2007 to November 2011, and the ankle brachial index （ABI） of these cases was 0 - 0.4 before our therapy. The efficacy of endovascular treatment of these cases was assessed. Results The rate of technical success was 91.8% （45/49）. Compared with the treatment before, average ABI elevation was 0.24 ± 0.13 （ P 〈 0.05 ）. After therapy, the symptom alleviated completely in 36 cases, turned better in 4 cases, and had no obvious improvement in 3 cases. Amputation rate during follow - up period was 5% （ 2/40）, and the mortality rate was 2.5 % （1/40）. Conclusion Endovascular treatment is mini - in- vasive and repetitive. Percutaneous transluminal angioplasty （PTA） combined with percutaneous transluminal angioplasty and stenting （PTAS） as first surgery method in refractory ASO has a satisfactory short- term result, but its long- term investigation is needed.
出处
《安徽医学》
2013年第4期398-400,共3页
Anhui Medical Journal
关键词
动脉硬化
腔内治疗
球囊扩张
支架
Arteriosclerosis
Endovascular treatment
Balloon dilatation
Stent
